Cookies: Information & Consent

We have placed cookies on your device to help make this website better. Some of the cookies we use are essential for this site to work. We also use some non-essential cookies to collect information for making reports and to help us improve the site. You will find more detailled information in our Privacy Chart.

March 2020

Banook Group welcomes Turenne Santé as new investor, alongside the management

Funds obtained will enable the European leader in cardiac safety to continue its…
Read the full post
May 2018

Webinar : Advances in cardiovascular diagnostic devices for clinical trial

Tuesday, May 29th, 2018  6:00 PM CEST (Central European Time) UTC/GMT + 2…
Read the full post
April 2017

Event Participation 2017

Banook Group will attend the following exhibitions. Let’s meet there!
Read the full post
February 2017

Cardiabase by Banook Group opens subsidiary in Montreal, Canada

Group strengthens its presence in North American market, aiming for 30% growth in…
Read the full post
March 2015

Banook Group - New branding announcement

Cardiabase/Banook Central Imaging becomes Banook Group - New branding announcement.
Read the full post
March 2014

Webinar: Imaging anti-cancer treatment response at a preclinical and clinical stage

Use of imaging in oncology clinical trials is mainly based on morphological evaluation…
Read the full post
Expertises > Medical & regulatory

Medical & regulatory

No two studies are alike


Oncology studies, in particular, present a number of additional challenges beyond the traditional issues of regular clinical trials. To successfully address these challenges, working with professionals that have a strong background and extensive expertise in oncology in general, and the type of cancer investigated in your study in particular, is essential. The earlier you engage these experts the more likely your trial will be designed and conducted in a manner that meets your protocol specifications and overall expectations.

The Banook Group Chief Medical Officers are active participants in Drug Advisory Committees and the Cardiac Safety Research Consortium (CSRC). They have broad experience in interacting with regulatory authorities, conducting face to face meetings with them in the US, Europe and other regions of the world (FDA, EMEA, ANSM, PMDA, Health Canada), and taking part in Data Safety Monitoring Boards in a chairman or expert role.


Moreover, the Banook Group has also extensive experience interacting and consulting with sponsors on the design and conduct of clinical programs and related activities, such as protocol writing, study design, analysis and reporting. These years of experience ensure we have a thorough understanding of your needs and operating procedures and can work with you effectively in the management of clinical data acquisition and analysis in your project.